Kindstar Globalgene Technology, Inc. (9960.HK)
HKD 1.12
(0.0%)
HKD 1.12
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.04 CNY | -54.58% |
| 2022 | 0.09 CNY | 103.24% |
| 2021 | -2.93 CNY | -171.3% |
| 2020 | -1.08 CNY | -468.42% |
| 2019 | -0.19 CNY | -226.46% |
| 2018 | -0.06 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.01 CNY | 0.0% |
| 2024 Q1 | 0.01 CNY | 267.57% |
| 2023 Q3 | -0.00 CNY | -116.09% |
| 2023 FY | - CNY | -54.58% |
| 2023 Q4 | -0.00 CNY | 0.0% |
| 2023 Q2 | 0.02 CNY | 0.0% |
| 2023 Q1 | 0.02 CNY | 132.32% |
| 2022 Q4 | 0.01 CNY | 0.0% |
| 2022 Q2 | 0.03 CNY | 0.0% |
| 2022 Q1 | 0.03 CNY | 7.53% |
| 2022 FY | - CNY | 103.24% |
| 2022 Q3 | 0.01 CNY | -67.0% |
| 2021 Q1 | -5.17 CNY | -37.5% |
| 2021 FY | - CNY | -171.3% |
| 2021 Q2 | -5.17 CNY | 0.0% |
| 2021 Q4 | 0.03 CNY | 0.0% |
| 2021 Q3 | 0.03 CNY | 100.54% |
| 2020 Q4 | -3.76 CNY | 0.0% |
| 2020 Q1 | -0.43 CNY | 0.0% |
| 2020 FY | - CNY | -468.42% |
| 2020 Q3 | -3.76 CNY | -774.42% |
| 2020 Q2 | -0.43 CNY | 0.0% |
| 2019 FY | - CNY | -226.46% |
| 2018 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | -0.04 HKD | 220.397% |
| UMP Healthcare Holdings Limited | 0.05 HKD | 16.339% |
| Human Health Holdings Limited | 0.06 HKD | 33.281% |
| EuroEyes International Eye Clinic Limited | 0.40 HKD | 89.375% |
| Kato (Hong Kong) Holdings Limited | 0.06 HKD | 33.801% |
| Bamboos Health Care Holdings Limited | 0.08 HKD | 45.019% |
| Beijing Health (Holdings) Limited | -0.01 HKD | 516.667% |
| C-MER Eye Care Holdings Limited | 0.05 HKD | 13.968% |
| Town Health International Medical Group Limited | -0.03 HKD | 248.084% |
| Medicskin Holdings Limited | -0.01 HKD | 651.948% |
| Hang Chi Holdings Limited | 0.06 HKD | 27.35% |